about
Twice upon a time: PI3K's secret double life exposedPhosphoinositide 3-kinase γ protects against catecholamine-induced ventricular arrhythmia through protein kinase A-mediated regulation of distinct phosphodiesterasesBleeding prevalence and transfusion requirement in patients with thrombocytopenia in the emergency department.Essential role of the p110beta subunit of phosphoinositide 3-OH kinase in male fertility.Recent advances in diagnosis and treatment of primary aldosteronism.Recent advances in diagnosis and treatment of pheochromocytoma.Therapeutic potential of endothelial progenitor cells in cardiovascular diseases.Nuclear hormone receptor LXRα inhibits adipocyte differentiation of mesenchymal stem cells with Wnt/beta-catenin signalingPlasma Lactate Dehydrogenase Levels Predict Mortality in Acute Aortic Syndromes: A Diagnostic Accuracy and Observational Outcome StudyDiagnosis and treatment of low-renin hypertension.Nuclear hormone receptors as regulators of the renin-angiotensin-aldosterone system.Aldosterone as an independent factor in cerebrovascular damage.Phosphoinositide 3-kinase signalling in the vascular system.Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury.Myocyte signalling in leucocyte recruitment to the heart.Diagnostic performance of the aortic dissection detection risk score in patients with suspected acute aortic dissection.Combined use of aortic dissection detection risk score and D-dimer in the diagnostic workup of suspected acute aortic dissection.Diagnostic performance of emergency transthoracic focus cardiac ultrasound in suspected acute type A aortic dissection.Biomarkers for diagnosis and prognostic stratification of aortic dissection: challenges and perspectives.Lung Ultrasound-Implemented Diagnosis of Acute Decompensated Heart Failure in the ED: A SIMEU Multicenter Study.Thrombopoietin as Early Biomarker of Disease Severity in Patients With Acute Pancreatitis.Therapeutic Targeting of PDEs and PI3K in Heart Failure with Preserved Ejection Fraction (HFpEF).Aldosterone does not modify gene expression in human endothelial cells.Integrating cardiac PIP3 and cAMP signaling through a PKA anchoring function of p110γ.Teratocarcinoma-derived growth factor-1 is upregulated in aldosterone-producing adenomas and increases aldosterone secretion and inhibits apoptosis in vitro.Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms.Bradykinin B2 receptor gene C-58T polymorphism and insulin resistance. A study on obese patients.Diagnostic Accuracy of the Aortic Dissection Detection Risk Score Plus D-Dimer for Acute Aortic Syndromes: The ADvISED Prospective Multicenter Study.Lost in perfusion.A man with sudden loss of consciousness.Phosphoinositide 3-Kinase Gamma Inhibition Protects from Anthracycline Cardiotoxicity and Reduces Tumor Growth.Comparison of clinical scores for identification of patients with pulmonary embolism at intermediate-high risk of adverse clinical outcome: the prognostic role of plasma lactate.Short-term clinical outcome of normotensive patients with acute PE and high plasma lactate.Liver X receptor activation reduces angiogenesis by impairing lipid raft localization and signaling of vascular endothelial growth factor receptor-2.Early cardiovascular autonomic dysfunction, beta cell function and insulin resistance in obese adolescents.PI3K signaling: a crossroads of metabolic regulationProspective diagnostic and prognostic study of copeptin in suspected acute aortic syndromesPulse rate in childhood: reference limits[Role of aldosterone in the metabolic syndrome]
P50
Q24317406-BAEC12FE-3575-4F0A-892A-09AF606BC5E7Q28506771-943C1614-2EEE-4E5A-B308-4586300CCC67Q33415195-DB88B3EE-B84C-44B4-B368-DAE6F67D1FD0Q33689775-EEA22CE9-0C4F-47E7-BE08-4DE6061AAFDCQ35578953-FF4E7C29-C0D1-4663-B0C5-30CF8A66F19DQ35578958-7E2395EB-A451-4C87-958E-C4A3B1E2A930Q36163172-0532A3AD-132F-42A5-99E7-5132710A094CQ36515398-17C56043-4BB0-492B-AF27-293C1A8799FCQ36581112-2683CA75-8F2B-4C28-BDBE-C45D824B0F41Q36851195-4CD6177B-D7AE-40F7-9EE3-7CD401128E9FQ37138817-4501F212-7352-4D4A-ACE1-74762129A3EAQ37330163-675022E6-F766-41E6-8926-117E480B8C77Q37336506-812DF7D0-D0C4-4886-AAE2-73DC7A5D5E74Q37484960-CC1670E1-66CC-45DC-A634-B16990E6CDF5Q38185647-020E02C3-7C35-4EE2-9304-2520ED69EF13Q38194100-939F23DC-2AA2-4ED5-9D3E-9541986FBBC8Q38212533-CE17FAE3-60FE-44FE-A4B8-DBAB6CF916C2Q38215671-2677FBE8-7A3E-4E60-AD55-46656AB18614Q38259356-CD8BECB8-40E9-4AC1-9439-4715F32B708EQ38345177-5AB91D8A-E751-424D-803F-36A6F1575C29Q39025071-1176C587-1B7A-4F80-9A08-41F97C721ACAQ39268911-C215F03F-D6E2-40F3-B7AC-A8A11824F36DQ39446158-E97CB301-0310-44A1-8A46-976C05B20768Q39562288-4820F48C-8DDB-466E-9401-C2E8AA231A97Q39715556-049553E0-E904-41F1-A52A-A026B6175452Q44240420-2F1D0660-E693-49CC-A3BB-72D422F9B933Q46019644-BC7DD4D7-5FC9-4963-BDEF-07C803C359E1Q47682665-CCE78CEF-8B88-4E3F-ABEC-5B014AF9EA2EQ48631760-7DF7F241-6386-4ED1-8E9D-875BFE0FD5B8Q48771945-179E6E6D-8458-4C7C-A9EC-5486EEEC6113Q49913324-561B0593-C496-4BBE-8E18-5EACDD73BF9FQ49953587-CE26E062-2148-4236-B131-BE432802ACABQ51500685-40D6843A-42D2-426C-A8C8-D936B9C250CFQ51660643-E17FE164-E5A6-44B9-861B-C7B677E01039Q54502518-585BC41E-1251-4043-9B7F-3D5266F7B20BQ54581330-D240EDBA-E58E-4A84-8A40-F891F66CDB61Q57006161-C8B1E171-D6D4-4C7A-9648-9F0BB6C2C4D8Q59335278-A15A992E-E691-4CC4-AC33-FE3F04145262Q75239566-4EF4D75D-58F9-4372-B419-8817ED3F1EC4Q79298545-056E62DE-75EC-4430-9CFC-33D40ABD4AE0
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Fulvio Morello
@ast
Fulvio Morello
@en
Fulvio Morello
@es
Fulvio Morello
@nl
type
label
Fulvio Morello
@ast
Fulvio Morello
@en
Fulvio Morello
@es
Fulvio Morello
@nl
prefLabel
Fulvio Morello
@ast
Fulvio Morello
@en
Fulvio Morello
@es
Fulvio Morello
@nl
P106
P1153
7003939415
P31
P496
0000-0002-7833-9632